The companies that had originally nominated the peptides for restriction withdrew their nominations, and on April 15, 2026 the FDA published the action, with the peptides coming off the Category 2 list effective April 22 to 23, 2026
Mood Swings Too much vitamin B can affect both your body and your mind
In retinal detachment or vascular occlusion, this multi-factorial approach addresses ischemia, inflammation, cell death, and tissue damage simultaneously
Contains 0.9% benzyl alcohol for multi-use laboratory applications
Multi-peptide blend featuring GHK-Cu, KPV, BPC-157, and TB-500 Studied in tissue signaling, inflammatory pathway, and barrier-function models Commonly explored for collagen dynamics and cellular migration research Relevant to tissue remodeling and regulation under sustained stress conditions Product Usage Notice: This product is intended strictly for research and laboratory use only